| CAS No.: | 1401708-83-5 |
|---|---|
| Formula: | C27h44n4o5 |
| Type: | Pharmaceutical Intermediates |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Dihexa | CAS No. | 1401708-83-5 |
| Molecular formula | C27H44N4O5 | Molecular weight | 504.66 |
| EINECS No. | 227-005-2 | Appearance | White powder |
| Purity | 99% | Function | Anti Alzheimer's |
Dihexa requires more testing and clinical trials to prove both its safety and the benefits that it can provide. As only animal testing has currently been done on the nootropic, the potential benefits of the drug are not guaranteed. The possible benefits of the nootropic drug include:
Dihexa has only been lab and animal tested, so the inherent risk factors of the drug are not widely known. Personal accounts of individuals taking the drug give some insight into the possible risks, but the overall safety of long term use is still unclear. The use of the drug short term does pose the possibility of side effects. Potential side effects include a reduced attention span, irritability, mood swings, change of taste, increased anxiety, nausea, and insomnia.
| BATCH NO.: HF171202 | QUANTITY:75.1kg | ||
| MFG. DATE : Dec., 2, 2017 | SPECIFICATION: As required | ||
| REP. DATE : Dec.4, 2017 | EXP. DATE : Dec., 2019 | ||
| ITEMS |
STANDARDS |
RESULTS |
|
Appearance |
White or off-white crystalline powder | Off-white crystalline powder | |
| Identification | By IR | Complies | |
| RT under chirality should complies | Complies | ||
| Chloride: it gives a reaction of chloride | Complies | ||
| Water | 3.0%~4.5% | 3.4% | |
Melting Point |
198.0~202.0ºC | 199.8~200.5ºC | |
| Residue on Ignition | ≤0.2% | 0.08% | |
| Heavy Metals | ≤10ppm | Complies | |
| Related Substances | Individual Impurities:≤0.5% | 0.15% | |
| Total Impurities:≤1.0% | 0.22% | ||
| Residual Solvent | ≤0.06% | 0.0066% | |
| ≤0.5% | 0.015% | ||
| ≤0.5% | 0.0013% | ||
| E.E | ≥99.0% | 99.6% | |
Assay (on dry basis) |
98.0%~102.0% | 101.2% | |
| Conclusion:It complies to prescribed enterprise standard. | |||
|
Product Name
|
Cas No. |
Product Name | Cas No. |
| Abaloparatide | 247062-33-5 | Acetyl Hexapeptide-8 | 616204-22-9 |
| ARA290 | 1208243-50-8 | Copper Peptide | 49557-75-7 |
| Adipotide/ FTPP | 72432-10-1 | Nonapeptide-1/Melitane | 158563-45-2 |
| Aviptadil Acetate | 40077-57-4 |
Myristoyl Pentapeptide-17 |
959610-30-1 |
| Atosiban Acetate | 90779-69-4 | Hexapeptide-9 |
616204-22-9 |
| Bivalirudin | 128270-60-0 | Palmitoyl Tripeptide-1 | 147732-56-7 |
| Dihexa | 1401708-83-5 | Arginine/Lysine Polypeptide | 936616-33-0 |
| Calcitonin Salmon | 47931-85-1 | Acetyl Hexapeptide-1 | 448944-47-6 |
Cetrorelix Acetate |
120287-85-6 | Decapeptide-12 | 137665-91-9 |
| Eptifibatide | 188627-80-7 |
Dipeptide Diaminobutyroyl |
823202-99-9 |
| Elamipretide | 736992-21-5 | Acetyl Tetrapeptide-5 |
827306-88-7 |
| DSIP | 62568-57-4 | Oligopeptide-1 | 727957-37-0 |
| Epithalon | 307297-39-8 | L-Carnosine | 305-84-0 |
| Thymulin | 63958-90-7 | Palmitoyl Tripeptide-5 |
623172-56-5 |
L-Glutathione Reduced |
70-18-8 | LZ1 peptide | 1565763-62-3 |
| N-Acetyl Epithalon |
307297-39-8 |
Thymosin Alpha-1 | 62304-98-7 |
| Teriparatide | 52232-67-4 | ||
| Melanotan-II | 121062-08-6 | N/A | |
| Octreotide Acetate | 83150-76-9 | Thymalfasin | 69440-99-9 |
| Oxytocin | 50-56-6 | Somatostatin | 51110-01-1 |
| Pramlintide | 196078-30-5 | N-Acetyl Selank | 129954-34-3 |
| Protirelin | 24305-27-9 | Selank | 129954-34-3 |
| 782487-28-9 | N-Acetyl Semax | 2920938-90-3 | |
| Semax | 80714-61-0 | Oligopeptide-20 | 1206525-47-4 |
Pentapeptide-18 |
64963-01-5 |
Peptide Tripeptide-32 |
2239-67-0 |
Myristoyl Tripeptide-31 |
/ |
Acetyl Hexapeptide-37 |
1447824-16-9 |
Q1: What's your MOQ?
){kind=link}